Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Characterizing Sleep Among Long-term Survivors of Childhood Cancer

NCT: NCT05480904 · RECRUITING

NCT IDNCT05480904
StatusRECRUITING
Start Date2023-04-17
Completion2027-01

Brief Summary

The patients are being asked to take part in this clinical trial because they received cancer treatment as a child at St. Jude. The study comprehensively examines sleep among three distinct diagnostic groups of survivors in the SJLIFE cohort: ALL, CNS tumors, and non-CNS solid tumors. Primary Objective The primary aim of this protocol is to estimate the prevalence of various sleep disorders among long-term survivors of childhood ALL, CNS tumors, and non- CNS solid tumors. Exploratory Objective The exploratory objective of the study is to explore associations between the prevalence of sleep disorders and clinical outcomes collected in SJLIFE.

Frequently Asked Questions

What is Characterizing Sleep Among Long-term Survivors of Childhood Cancer?

Characterizing Sleep Among Long-term Survivors of Childhood Cancer is a clinical trial registered under NCT05480904. Current status: RECRUITING.

What is the status of NCT05480904?

The current status of NCT05480904 (Characterizing Sleep Among Long-term Survivors of Childhood Cancer) is: RECRUITING.

When did Characterizing Sleep Among Long-term Survivors of Childhood Cancer start?

Characterizing Sleep Among Long-term Survivors of Childhood Cancer started on 2023-04-17.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.